AREBW's net losses substantially expanded while revenue declined and cash position deteriorated, creating significant liquidity concerns.
The company faces mounting financial distress with net losses roughly doubling alongside declining revenue, indicating operational challenges are intensifying rather than improving. The combination of shrinking cash reserves (down nearly 49% to just $148K) and substantially increased current liabilities signals potential near-term liquidity issues that could threaten business continuity.
AREBW's financial position deteriorated meaningfully across key metrics, with revenue declining 21% to under $1M while net losses substantially expanded. The balance sheet shows concerning liquidity pressure as cash reserves fell to a minimal $148K while current liabilities increased 70% to $26M. The company's pivot from beer operations to minority interest acquisitions like the Schmitty's investment appears to be a strategic shift amid ongoing operational struggles.
Net income declined 95% — review whether driven by operations, interest costs, or non-recurring items.
R&D spending cut 79.6% — could signal cost discipline or concerning reduction in innovation investment.
Current liabilities surged 70.1% — significant near-term obligations; verify ability to meet short-term debt.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Liabilities grew 55.6% — significant increase in debt or obligations, assess impact on financial flexibility.
Cash declined 48.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Inventory drawn down 39.5% — strong sell-through or deliberate destocking; watch for supply constraints.
Revenue softened 21.4% — monitor whether this is cyclical or structural.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
Receivables declined — improved collection efficiency or conservative revenue recognition.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →